Literature DB >> 29558234

Development of a stability-indicating UPLC method for determination of isotretinoin in bulk drug.

Shih-Liang Hsi1,2, Peter Surman2, Raida Al-Kassas1.   

Abstract

A highly sensitive and rapid stability indicating ultra-performance liquid chromatographic (UPLC) method was developed for the quantification and identification of isotretinoin in bulk. Chromatographic separation was developed using a gradient elution in a reversed-phase system at flow rate of 0.5 ml/min with 12 min run time. The mobile phase was a gradient mixture of mobile phase A (contained a 30:70:0.5 mixture solution of methanol/purified water/glacial acetic acid) and mobile phase B (contained a 70:25:4.5:0.5 mixture solution of methanol/acetonitrile/purified water/glacial acetic acid). Eluents were monitored at 355 nm. The analytical method was validated for accuracy, precision, robustness, linearity, and forced degradation in accordance with the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) topic Q2 (R1) 'Validation of Analytical Procedures: Text and Methodology'. The method was linear over a concentration range of (1-7 µg/ml) with correlation coefficient of (r2 > 0.9999). The accuracy was confirmed by calculating the % recovery which was found to be 100.0-101.6%. The RSD values obtained for repeatability and intermediate precision experiments were less than 2%. The limit of detection (LOD) was 0.12 µg/ml, while the limit of quantification (LOQ) was 0.38 µg/ml. The drug samples were exposed to different stressed conditions and the results showed that all degradation products were satisfactorily separated from each other and from the peak of the drug using the developed method. The proposed method can be used for the quantitative determination of isotretinoin with confidence.

Entities:  

Keywords:  ICH guidelines; Isotretinoin; UPLC; forced degradation studies; method development

Mesh:

Substances:

Year:  2018        PMID: 29558234     DOI: 10.1080/10837450.2018.1454469

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  1 in total

1.  Antiviral Activity Against Infectious Bronchitis Virus and Bioactive Components of Hypericum perforatum L.

Authors:  Huijie Chen; Ishfaq Muhammad; Yue Zhang; Yudong Ren; Ruili Zhang; Xiaodan Huang; Lei Diao; Haixin Liu; Xunliang Li; Xiaoqi Sun; Ghulam Abbas; Guangxing Li
Journal:  Front Pharmacol       Date:  2019-10-29       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.